We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+38.8%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$3.79B
AUM Growth
+$1.43B
(+60%)
Cap. Flow
+$661M
Cap. Flow
% of AUM
17.45%
Top 10 Holdings %
Top 10 Hldgs %
59.79%
Holding
60
New
6
Increased
1
Reduced
4
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DM
Desktop Metal, Inc.
DM
|
+$376M |
| 2 |
EAR
Eargo, Inc. Common Stock
EAR
|
+$275M |
| 3 |
Opendoor
OPEN
|
+$144M |
| 4 |
Palo Alto Networks
PANW
|
+$75.3M |
| 5 |
Upstart Holdings
UPST
|
+$23.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sprout Social
SPT
|
+$119M |
| 2 |
MRSN
Mersana Therapeutics
MRSN
|
+$111M |
| 3 |
ALLK
Allakos
ALLK
|
+$10.8M |
| 4 |
DraftKings
DKNG
|
+$1.41M |
| 5 |
Senseonics Holdings Inc
SENS
|
+$1.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.98% |
| 2 | Industrials | 13.91% |
| 3 | Technology | 12.25% |
| 4 | Real Estate | 4% |
| 5 | Consumer Discretionary | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Marker Therapeutics
MRKR
$18.7M
| $7.25M | 0.19% |
500,000
| – | – |
|
|
PHXM
52
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
| $5.77M | 0.15% |
62,500
| – | – |
|
|
TCON
53
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $4.06M | 0.11% |
17,336
| – | – |
|
54
Tempest Therapeutics
TPST
$14.6M
| $3.78M | 0.1% |
9,060
| – | – |
|
55
Palantir
PLTR
$413B
| $1.41M | 0.04% |
59,980
-14,994
| -20% | -$268K |
|
|
AKTX
56
Akari Therapeutics
AKTX
$12.3M
| $837K | 0.02% |
565
| – | – |
|
|
VIRX
57
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $258K | 0.01% |
37,093
| – | – |
|
|
58
DraftKings
DKNG
$11.9B
| – | – |
-23,902
| Closed | -$1.41M |
|
|
MRSN
59
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-238,381
| Closed | -$111M |
|
|
ALTR
60
DELISTED
Altair Engineering Inc
ALTR
| – | – |
-11,977
| Closed | -$503K |
|
Similar funds
NM
SLF
CGH
CIP
DF
HHAM
SFI
VCM
NEA Management Company's Q4 2020 Portfolio in Review
As of Q4 2020, NEA Management Company held 60 positions worth $3.79B, up 60% from $2.36B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
NEA Management Company deployed $661M of net new capital in Q4 2020, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Desktop Metal, Inc.: 2,841,609 shares worth $489M.
By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 84% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Sprout Social, an estimated $119M trimmed.
- NEA Management Company's largest Q4 2020 buy was Desktop Metal, Inc.: 2,841,609 shares worth $489M.
- NEA Management Company added most to Regulus Therapeutics in Q4 2020, an estimated $3.23M increase.
- NEA Management Company's biggest Q4 2020 reduction was Sprout Social, cutting an estimated $119M.
- NEA Management Company fully exited Mersana Therapeutics in Q4 2020, selling an estimated $111M.
- NEA Management Company's ten largest holdings make up 60% of its $3.79B portfolio in Q4 2020.
- NEA Management Company opened 6 new positions and closed 3 in Q4 2020.
- NEA Management Company's portfolio value rose 60% quarter-over-quarter to $3.79B.
Based on NEA Management Company's 13F filing for Q4 2020, filed 16 Feb 2021.